Ignite Creation Date:
2024-05-05 @ 7:28 PM
Last Modification Date:
2024-10-26 @ 9:49 AM
Study NCT ID:
NCT00677924
Status:
TERMINATED
Last Update Posted:
2023-07-18
First Post:
2008-05-13
Brief Title:
Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer
Sponsor:
Genmab
Organization:
Genmab
Organization Data
Organization:
Genmab
Class:
INDUSTRY
Study ID:
GEN206
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genmab
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None